Background: Androgen ablation is often used in addition to low-dose-rate brachytherapy in the treatment of prostate cancer, particularly for disease with adverse features. We report a single ...
Table I displays demographic, disease and treatment information for the whole cohort based on androgen ablation. Table II displays the characteristics of the EBRT and no-EBRT subgroups.